# A Study to Learn About How Well BAY3283142 Works and Its Safety in Participants With Chronic Kidney Disease

> **NCT06522997** · PHASE2 · COMPLETED · sponsor: **Bayer** · enrollment: 1222 (actual)

## Conditions studied

- Chronic Kidney Disease

## Interventions

- **DRUG:** BAY3283142
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06522997
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-08-08
- **Primary completion:** 2025-10-24
- **Final completion:** 2025-11-20
- **Target enrollment:** 1222 (ACTUAL)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06522997

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06522997, "A Study to Learn About How Well BAY3283142 Works and Its Safety in Participants With Chronic Kidney Disease". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06522997. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*